Siegfried Reich
Plus aucun poste en cours
Profil
Siegfried Reich a fondé eFFECTOR Therapeutics, Inc. Le Dr Reich est directeur scientifique et vice-président exécutif de Turning Point Therapeutics, Inc. Dans le passé, il a occupé le poste de vice-président chez Pfizer Inc. et de directeur et chef de la chimie médicinale chez Agouron Pharmaceuticals LLC (une filiale de Pfizer Inc.), de premier vice-président de la recherche chez eFFECTOR Therapeutics, Inc. et de vice-président de la découverte de médicaments chez SGX Pharmaceuticals, Inc. Siegfried Reich a obtenu un diplôme de premier cycle à l'université d'État de San Diego et un doctorat à l'université de Californie, Irvine.
Anciens postes connus de Siegfried Reich
| Sociétés | Poste | Fin |
|---|---|---|
| TURG POIN | Chief Tech/Sci/R&D Officer | 04/03/2022 |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 18/04/2011 |
| PFIZER, INC. | Corporate Officer/Principal | 01/12/2005 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Director/Board Member | 01/01/2001 |
| EFFECTOR THERAPEUTICS, INC. | Founder | - |
Formation de Siegfried Reich
| San Diego State University | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Commercial Services |
